I -2 GLU 21 -26.308 -25.697
I -1 THR 24 -22.259 -22.460
I 0 GLY 16 -20.301 -19.806
I 1 ALA 9 -18.472 -17.382
I 2 LYS 12 -24.482 -23.046
I 3 VAL 29 -27.499 -27.672
I 4 THR 4 -24.538 -22.176
I 5 VAL 13 -25.140 -23.744
I 6 ASP 2 -20.481 -18.356
I 7 THR 29 -24.105 -24.668
I 8 VAL 2 -21.968 -19.672
I 9 CYS 26 -27.593 -27.410
I 10 LYS 9 -24.064 -22.332
I 11 ARG 14 -24.954 -23.694
I 12 GLY 28 -29.407 -29.245
I 13 PHE 19 -30.144 -28.862
I 14 LEU 25 -33.664 -32.667
I 15 ILE 21 -32.698 -31.353
I 16 GLN 24 -30.742 -29.967
I 17 MET 29 -26.306 -26.615
I 18 SER 26 -22.170 -22.610
I 19 GLY 28 -21.649 -22.379
I 20 HIS 26 -27.264 -27.119
I 21 LEU 22 -30.626 -29.634
I 22 GLU 33 -31.691 -31.841
I 23 CYS 29 -34.852 -34.179
I 24 LYS 16 -35.526 -33.280
I 25 CYS 18 -32.102 -30.480
I 26 GLU 9 -25.053 -23.207
I 27 ASN 4 -21.789 -19.743
I 28 ASP 5 -20.097 -18.360
I 29 LEU 19 -22.838 -22.397
I 30 VAL 22 -24.878 -24.547
I 31 LEU 27 -29.531 -29.240
I 32 VAL 16 -23.923 -23.011
I 33 ASN 11 -26.458 -24.681
I 34 GLU 23 -30.833 -29.932
I 35 GLU 10 -28.247 -26.149
I 36 THR 15 -26.656 -25.316
I 37 CYS 17 -26.415 -25.332
I 38 GLU 16 -21.097 -20.511
I 39 GLU 4 -18.298 -16.654
I 40 LYS 25 -19.613 -20.233
I 41 VAL 18 -17.517 -17.572
I 42 LEU 1 -15.111 -13.489
I 43 LYS 3 -14.926 -13.554
I 44 CYS 19 -15.988 -16.334
I 45 ASP 3 -11.865 -10.846
I 46 GLU 3 -9.176 -8.466
I 47 LYS 4 -9.193 -8.596
I 48 THR 18 -13.318 -13.857
I 49 VAL 10 -14.435 -13.925
I 50 ASN 0 -14.874 -13.163
I 51 LYS 14 -16.504 -16.216
I 52 PRO 16 -21.550 -20.912
I 53 CYS 25 -21.545 -21.942
I 54 GLY 20 -24.438 -23.928
I 55 ASP 21 -28.968 -28.051
I 56 PHE 23 -28.112 -27.524
I 57 SER 24 -24.297 -24.263
I 58 LYS 17 -20.804 -20.367
I 59 CYS 19 -16.594 -16.871
I 60 ILE 16 -13.653 -13.923
I 61 LYS 7 -10.091 -9.736
I 62 ILE 14 -9.007 -9.581
I 63 ASP 0 -6.188 -5.477
I 64 GLY 10 -4.441 -5.080
I 65 ASN 0 -2.318 -2.051 <=B
I 66 PRO 2 -3.725 -3.527 <=B
I 67 VAL 9 -5.444 -5.853
I 68 SER 6 -8.622 -8.320
I 69 TYR 17 -11.835 -12.429
I 70 ALA 14 -15.086 -14.961
I 71 CYS 21 -18.968 -19.202
I 72 LYS 14 -19.079 -18.495
I 73 CYS 18 -23.500 -22.867
I 74 ASN 19 -22.682 -22.259
I 75 LEU 2 -19.244 -17.261
I 76 GLY 17 -21.372 -20.869
I 77 TYR 27 -23.171 -23.611
I 78 ASP 12 -21.734 -20.614
I 79 MET 11 -22.407 -21.095
I 80 VAL 16 -20.793 -20.242
I 81 ASN 8 -18.239 -17.062
I 82 ASN 1 -19.789 -17.628
I 83 VAL 9 -25.965 -24.014
I 84 CYS 23 -27.334 -26.835
I 85 ILE 22 -25.931 -25.479
I 86 PRO 24 -22.951 -23.071
I 87 ASN 10 -17.403 -16.552
I 88 GLU 15 -13.650 -13.805
I 89 CYS 30 -17.758 -19.166
I 90 LYS 8 -15.674 -14.791
I 91 GLN 3 -10.518 -9.653
I 92 VAL 28 -12.276 -14.084
I 93 THR 4 -11.141 -10.320
I 94 CYS 30 -13.531 -15.425
I 95 GLY 14 -10.824 -11.189
I 96 ASN 19 -14.482 -15.002
I 97 GLY 36 -20.533 -22.312
I 98 LYS 20 -24.822 -24.267
I 99 CYS 24 -23.949 -23.954
I 100 ILE 28 -25.075 -25.411
I 101 LEU 20 -19.811 -19.833
I 102 ASP 13 -15.973 -15.631
I 103 THR 13 -16.575 -16.164
I 104 SER 5 -10.639 -9.991
I 105 ASN 13 -7.507 -8.139
I 106 PRO 0 -4.727 -4.183
I 107 VAL 2 -6.805 -6.252
I 108 LYS 14 -11.156 -11.483
I 109 THR 8 -11.165 -10.801
I 110 GLY 20 -13.959 -14.654
I 111 VAL 22 -15.397 -16.157
I 112 CYS 26 -18.383 -19.259
I 113 SER 26 -23.915 -24.155
I 114 CYS 22 -20.292 -20.489
I 115 ASN 14 -21.107 -20.289
I 116 ILE 20 -19.511 -19.567
I 117 GLY 12 -14.177 -13.926
I 118 LYS 26 -12.238 -13.820
I 119 VAL 8 -12.385 -11.880
I 120 PRO 16 -9.898 -10.600
I 121 ASN 18 -6.218 -7.573
I 122 VAL 0 -4.392 -3.887
I 123 GLN 6 -3.159 -3.486 <=B
I 124 ASP 16 -4.101 -5.469
I 125 GLN 10 -5.111 -5.673
I 126 ASN 14 -7.244 -8.021
I 127 LYS 10 -9.140 -9.239
I 128 CYS 26 -12.341 -13.912
I 129 SER 10 -6.913 -7.268
I 130 LYS 16 -6.102 -7.240
I 131 ASP 0 -6.314 -5.588
I 132 GLY 20 -8.873 -10.152
I 133 GLU 2 -11.842 -10.710
I 134 THR 30 -16.437 -17.996
I 135 LYS 1 -17.343 -15.464
I 136 CYS 21 -22.498 -22.325
I 137 SER 16 -21.883 -21.206
I 138 LEU 33 -26.194 -26.976
I 139 LYS 10 -21.538 -20.212
I 140 CYS 22 -24.236 -23.979
I 141 LEU 5 -20.011 -18.285
I 142 LYS 20 -20.339 -20.300
I 143 GLU 6 -16.416 -15.218
I 144 GLN 10 -16.664 -15.898
I 145 GLU 20 -19.682 -19.718
I 146 THR 7 -20.796 -19.210
I 147 CYS 17 -23.573 -22.817
I 148 LYS 15 -20.709 -20.053
I 149 ALA 13 -21.339 -20.380
I 150 VAL 16 -22.996 -22.192
I 151 ASP 4 -21.117 -19.149
I 152 GLY 14 -23.142 -22.090
I 153 ILE 17 -28.535 -27.208
I 154 TYR 25 -27.138 -26.893
I 155 LYS 17 -29.540 -28.097
I 156 CYS 24 -25.159 -25.026
I 157 ASP 15 -23.369 -22.407
I 158 CYS 8 -18.897 -17.644
I 159 LYS 9 -16.901 -15.992
I 160 ASP 0 -12.188 -10.786
I 161 GLY 1 -11.058 -9.901
I 162 PHE 16 -12.500 -12.903
I 163 ILE 0 -12.775 -11.306
I 164 ILE 4 -13.233 -12.172
I 170 ILE 5 -17.091 -15.701
I 171 CYS 17 -16.575 -16.624
I 172 THR 2 -10.870 -9.850

Identified 3 B-Cell epitope residues out of 170 total residues